Clincosm LogoSign in Get a demo

meningioma

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low Grade Glioma, Malignant Brain Glioma, Malignant Brain Tumor Trial in Atlanta (procedure, drug, other)

Not yet recruiting
  • Low Grade Glioma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Nov 7, 2023

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

Meningioma Trial in Heidelberg (Explorative biomarker study)

Not yet recruiting
  • Meningioma
  • Explorative biomarker study
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Oct 23, 2023

Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without

Recruiting
  • Meningioma
  • Radiation Toxicity
  • Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
  • +3 more
  • Caen, France
  • +1 more
Sep 13, 2023

Meningioma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Meningioma
  • Hyperpolarized carbon C 13 pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2023

Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

Not yet recruiting
  • Meningioma
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 21, 2023

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Role of the Tumor Microenvironment in Aggressive Meningiomas

Not yet recruiting
  • Meningioma
  • Surgical waste and Data collect
  • (no location specified)
Apr 7, 2023

Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

Recruiting
  • Meningioma
  • +2 more
  • Biological biomarker assessment
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023

Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

Not yet recruiting
  • Cognition
  • +5 more
  • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
  • +3 more
  • Gent, Belgium
  • +2 more
Feb 3, 2023

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Seizures, Meningioma Trial in Beijing (Tranexamic acid, 0.9% saline)

Active, not recruiting
  • Seizures
  • Meningioma
  • Tranexamic acid
  • 0.9% saline
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 1, 2023

Meningioma Trial in Austria, Germany, United States (Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI))

Active, not recruiting
  • Meningioma
  • Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
  • Phoenix, Arizona
  • +16 more
Dec 27, 2022

DOTATOC PET/CT for Imaging NET Patients

Recruiting
  • Neuroendocrine Tumors
  • +15 more
  • 68Ga-DOTATOC PET/CT
  • 18F-FDG PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 2, 2022

Meningioma Trial in Chicago, Boston (AZD2014)

Active, not recruiting
  • Meningioma
  • Chicago, Illinois
  • +2 more
Oct 15, 2022

Neurocognition & Neuroimaging in Primary BT Patients

Recruiting
  • Primary Brain Tumor
  • +3 more
    • San Diego, California
      Moores Cancer Center
    Oct 7, 2022

    Meningioma Trial (Endovascular embolization)

    Recruiting
    • Meningioma
    • Endovascular embolization
    • Trondheim, Norway
      St Olavs Hospital
    Oct 10, 2022

    Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • 90Y-DOTA tyr3-Octreotide
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 6, 2022

    Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

    Recruiting
    • Meningioma
    • Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 28, 2022

    Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

    Active, not recruiting
    • Meningioma
    • Meningioma, Adult
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 27, 2022

    68-Ga DOTATATE PET/MRI in Diagnosis and Management of

    Recruiting
    • CNS Tumors
    • +6 more
    • Ga68-DOTATATE-PET/MRI
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022

    Tranexamic Acid, Intraoperative Blood Loss, Meningioma Trial in Beijing (Continous infusion, Single infusion, Placebo)

    Recruiting
    • Tranexamic Acid
    • +2 more
    • Continous infusion
    • +2 more
    • Beijing, Beijing, China
      Beijing Tiantan Hospital, Capital Medical University
    Aug 24, 2022

    Meningioma Trial in Heidelberg (Carbon Ion Radiotherapy)

    Active, not recruiting
    • Meningioma
    • Carbon Ion Radiotherapy
    • Heidelberg, Germany
      University Hopsital Heidelberg
    Aug 23, 2022

    Meningioma Trial (Radiotherapy 68 Gy(RBE), Radiotherapy 72 Gy(RBE), Radiotherapy 60 Gy(RBE))

    Not yet recruiting
    • Meningioma
    • Radiotherapy 68 Gy(RBE)
    • +2 more
    • (no location specified)
    Aug 2, 2022

    Meningioma Trial in Miami (Cabozantinib)

    Recruiting
    • Meningioma
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    Jun 17, 2022